Does the use of over-the-counter vitamins and supplements have an effect on recurrence rates and survival seen with breast cancer patients? A recent research study set out to find the answer.
Women of color are 40% more likely to die from breast cancer than their white counterparts. Despite that fact, they make up only 6% of clinical trials for breast cancer treatments.
At just 25 years old, Shante’s medical team assured her the lump she found was unlikely to be cancer. Eventually diagnosed with ER+ breast cancer, she’s been advocating for herself ever since.
The decision to work during breast cancer treatment is personal and complicated. As the CEO of your life, you have the right to fearlessly, and strategically pursue your dreams upon conquering this battle.
The San Antonio Breast Cancer Symposium is the largest in the world. Learn about scholarships to attend, what to expect, and a 2018 recap.
It isn’t easy to advocate for yourself when dealing with cancer treatment, but it’s worth it. This is your body, and you deserve to have your reconstruction decision respected.
Most early-stage breast cancer patients with intermediate Oncotype DX scores do not benefit from chemotherapy; but for young women, a more nuanced examination is required.
YSC RISE Advocates weigh in on the research they’re excited about.
As a researcher whose main role is to engage patients and other stakeholders as we design and conduct a breast cancer clinical trial, RadComp, it is surprising to me that the involvement of patients and other stakeholders has not always been part of the picture.
Urging lawmakers to ensure coverage for all.
Advocating for healthcare equality and fertility options.
Using a grill as a starting point for advocacy.
A veteran journalist and survivor shares her thoughts on advocacy.
RISE Advocate and YSC board member shares her experiences with research advocacy.